[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE330625T1 - Enzymatische behandlung von retinitis pigmentosa und pharmazeutische zusammensetzung hierfür in form eines kits - Google Patents

Enzymatische behandlung von retinitis pigmentosa und pharmazeutische zusammensetzung hierfür in form eines kits

Info

Publication number
ATE330625T1
ATE330625T1 AT02785892T AT02785892T ATE330625T1 AT E330625 T1 ATE330625 T1 AT E330625T1 AT 02785892 T AT02785892 T AT 02785892T AT 02785892 T AT02785892 T AT 02785892T AT E330625 T1 ATE330625 T1 AT E330625T1
Authority
AT
Austria
Prior art keywords
kit
pharmaceutical composition
retinitis pigmentosa
enzymatic treatment
enzymes
Prior art date
Application number
AT02785892T
Other languages
English (en)
Inventor
Paola Ammannati
Roberto Giordani
Original Assignee
Paola Ammannati
Roberto Giordani
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paola Ammannati, Roberto Giordani filed Critical Paola Ammannati
Application granted granted Critical
Publication of ATE330625T1 publication Critical patent/ATE330625T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4813—Exopeptidases (3.4.11. to 3.4.19)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/01021—Aldehyde reductase (1.1.1.21), i.e. aldose-reductase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/01049—Glucose-6-phosphate dehydrogenase (1.1.1.49)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01—Peroxidases (1.11.1)
    • C12Y111/01009—Glutathione peroxidase (1.11.1.9)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/13—Dipeptidases (3.4.13)
    • C12Y304/13009—Xaa-Pro dipeptidase (3.4.13.9) i.e. prolidase

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT02785892T 2002-10-01 2002-10-01 Enzymatische behandlung von retinitis pigmentosa und pharmazeutische zusammensetzung hierfür in form eines kits ATE330625T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2002/000624 WO2004030693A1 (en) 2002-10-01 2002-10-01 Enzymatic treatment of retinitis pigmentosa and relevant pharmaceutical composition in form of a kit

Publications (1)

Publication Number Publication Date
ATE330625T1 true ATE330625T1 (de) 2006-07-15

Family

ID=32051201

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02785892T ATE330625T1 (de) 2002-10-01 2002-10-01 Enzymatische behandlung von retinitis pigmentosa und pharmazeutische zusammensetzung hierfür in form eines kits

Country Status (12)

Country Link
US (1) US7445777B2 (de)
EP (1) EP1545590B1 (de)
JP (1) JP2006504715A (de)
CN (1) CN1321691C (de)
AT (1) ATE330625T1 (de)
AU (1) AU2002349813A1 (de)
BR (1) BR0215896A (de)
CA (1) CA2500068A1 (de)
DE (1) DE60212729T2 (de)
ES (1) ES2266601T3 (de)
NZ (1) NZ538969A (de)
WO (1) WO2004030693A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0418858A (pt) * 2004-06-08 2007-11-20 Paola Ammannati tratamento enzimático de retinite pigmentosa e composição farmacêutica relevante para o mesmo na forma de um kit
US20110021974A1 (en) * 2010-10-05 2011-01-27 Shantha Totada R Retinitis pigmentosa treatment and prophalaxis
CA2922570A1 (en) * 2013-08-26 2015-03-05 Health Research, Inc. Method for prophylaxis and/or treatment of erbb2 positive cancers
CN107075490A (zh) 2014-08-20 2017-08-18 健康研究公司 用于预防和/或治疗erbb1阳性癌症的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2784030B1 (fr) 1998-10-02 2002-12-20 Inst Nat Sante Rech Med Utilisation de bloqueurs des canaux calciques et/ou cgmp-dependants pour le traitement de pathologies de la retine
FR2784898A1 (fr) 1998-10-26 2000-04-28 Univ Pasteur Utilisation du gdnf pour le traitement de la degenerescence retinienne

Also Published As

Publication number Publication date
EP1545590B1 (de) 2006-06-21
NZ538969A (en) 2006-06-30
AU2002349813A1 (en) 2004-04-23
DE60212729T2 (de) 2007-06-28
ES2266601T3 (es) 2007-03-01
CN1321691C (zh) 2007-06-20
CN1671411A (zh) 2005-09-21
US7445777B2 (en) 2008-11-04
WO2004030693A1 (en) 2004-04-15
JP2006504715A (ja) 2006-02-09
CA2500068A1 (en) 2004-04-15
EP1545590A1 (de) 2005-06-29
DE60212729D1 (de) 2006-08-03
BR0215896A (pt) 2005-08-09
US20060134088A1 (en) 2006-06-22

Similar Documents

Publication Publication Date Title
WO2005016227A3 (en) Methods and pharmaceutical compositions for modulating heparanase activation and uses thereof
WO2007067504A3 (en) Lactam compounds and methods of using the same
EP2260835A3 (de) Zusammensetzung zur Proteasomhemmung
WO2006045119A3 (en) Improved inhibitors for the soluble epoxide hydrolase
WO2007061939A3 (en) Metabolite derivatives of the hdac inhibitor fk228
AU2003287274A1 (en) Devices and methods for treating aortic valve stenosis
AU2003205315A1 (en) Methods and kits for delivering pharmaceutical agents into the coronary vascular adventitia
TW200504078A (en) Therapeutically active compounds and their use
PL375900A1 (en) Dosage forms containing a proton pump inhibitor, a nsaid, and a buffer
WO2005084295A3 (en) Fused heterotricyclic compounds as inhibitors of 17b-hydroxysteroid dehydrogenase 3
WO2005082341A3 (en) NON-PEPTIDYL AGENTS WITH pHSP20-LIKE ACTIVITY, AND USES THEREOF
WO2007097806A3 (en) Self-improvement system and method
HK1074592A1 (en) 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
MY135696A (en) Pyrrolidone derivatives as maob inhibitors
BR0307349A (pt) Processos para fermentar uma composição de fitoesterol e para preparar androestadienodiona a partir da androestenodiona, fusarium solani fmi 33, e, composição
DE50307131D1 (de) Darreichungsform zur oralen verabreichung von wirkstoffen, vitaminen und/oder nährstoffen
WO2004052236A3 (en) Methods and compositions for treatment of otitis media
WO2006063055A3 (en) Enzyme conjugates for use as detoxifying agents
WO2002004409A3 (en) Tetrahydrobenzothiazole analogues as neuroprotective agents
ATE330625T1 (de) Enzymatische behandlung von retinitis pigmentosa und pharmazeutische zusammensetzung hierfür in form eines kits
TW200738255A (en) Methods of regulating renalase (Monoamine Oxidase C)
PT1441708E (pt) Composições e métodos para aumentar a observância de terapias utilizando inibidores da aldeído desidrogenase e para tratar alcoolismo
WO2004044000A3 (en) Compounds and methods for modulating functions of classical cadherins
HUP0202638A2 (hu) Fermentált búzacsíra-kivonat alkalmazása gyulladáscsökkentő készítmények előállítására
WO2007015918A3 (en) Novel biologically active peptides and their new uses

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1545590

Country of ref document: EP

REN Ceased due to non-payment of the annual fee